|
[Achievements] Obtained certification and permission from the Ministry of Food and Drug Safety for Endoscopic Linear Stapler & Novel Asymmetrical Linear Stapler
|
|
[Publications and IP] Obtained certification and permission from the Ministry of Food and Drug Safety for Endoscopic Linear Stapler & Novel Asymmetrical Linear Stapler
|
|
[Investments] Secured investments of KRW 9.5 billion from Korean venture capitals in 2021
|
|
[Investments] Secured investments of KRW 30 billion from Korean venture capitals in 2022
|
|
[Publications and IP] 22 Overseas Patent Registration ( 3 US, 3 Japan, 3 China, 2 Germany, 2 France, 2 UK, 2 Italy, 2 Spain, 2 Netherlands, 1 India )
|
|
[Investments] Secured investments of KRW 2.5 billion from Korean venture capitals in 2020
|
|
[Investments] Secured investments of KRW 600 million from domestic individual investors' investment in 2019
|
|
[Achievements] MEDITULIP achieved ISO13485:2016 certification
|
|
[Achievements] MEDITULIP received approvals for the manufacturing of chemoports from the Korean Ministry of Food and Drug Safety
|
|
[Achievements] MEDITULIP's chemoport, a Class 4 medical device, passed the technical document review by the Korean Ministry of Food & Drug Safety on July 17th, 2019
|
|
[Achievements] MEDITULIP received a GMP Certificate from the Korean Ministry of Food & Drug Safety on May 14th, 2019
|
|
[Investments] Secured investments of KRW 3 billion from Korean venture capitals in 2018
|
|
[Investments] Secured investments of KRW 1.5 billion from Korean venture capitals in 2016
|
|
[Publications and IP] 5 overseas applications and 7 PCT applications
|
|
[Publications and IP] 10 domestic patent registrations
|
